Sirona Biochem Corp Stock Current Liabilities
| SRBCF Stock | USD 0.05 0 9.89% |
Sirona Biochem Corp fundamentals help investors to digest information that contributes to Sirona Biochem's financial success or failures. It also enables traders to predict the movement of Sirona Pink Sheet. The fundamental analysis module provides a way to measure Sirona Biochem's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sirona Biochem pink sheet.
Sirona |
Sirona Biochem Corp Company Current Liabilities Analysis
Sirona Biochem's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Sirona Biochem Current Liabilities | 801 K |
Most of Sirona Biochem's fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sirona Biochem Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
In accordance with the recently published financial statements, Sirona Biochem Corp has a Current Liabilities of 801 K. This is 99.95% lower than that of the Biotechnology sector and 99.85% lower than that of the Health Care industry. The current liabilities for all United States stocks is 99.99% higher than that of the company.
Did you try this?
Run Economic Indicators Now
Economic IndicatorsTop statistical indicators that provide insights into how an economy is performing |
| All Next | Launch Module |
Sirona Fundamentals
| Return On Equity | -35.56 | |||
| Return On Asset | -1.35 | |||
| Operating Margin | (4.92) % | |||
| Current Valuation | 24.5 M | |||
| Shares Outstanding | 251.73 M | |||
| Shares Owned By Insiders | 10.43 % | |||
| Price To Earning | (7.33) X | |||
| Price To Book | 36.93 X | |||
| Price To Sales | 36.46 X | |||
| Revenue | 268.02 K | |||
| Gross Profit | 199.25 K | |||
| EBITDA | (2.3 M) | |||
| Net Income | (2.31 M) | |||
| Cash And Equivalents | 1.13 M | |||
| Total Debt | 468.77 K | |||
| Debt To Equity | 0.60 % | |||
| Current Ratio | 2.60 X | |||
| Book Value Per Share | 0 X | |||
| Cash Flow From Operations | (2.16 M) | |||
| Earnings Per Share | (0.01) X | |||
| Number Of Employees | 12 | |||
| Beta | -0.36 | |||
| Market Capitalization | 20.74 M | |||
| Total Asset | 1.29 M | |||
| Retained Earnings | (12.03 M) | |||
| Working Capital | 692 K | |||
| Current Asset | 1.49 M | |||
| Current Liabilities | 801 K | |||
| Z Score | 10.5 | |||
| Net Asset | 1.29 M |
About Sirona Biochem Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sirona Biochem Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sirona Biochem using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sirona Biochem Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Sirona Pink Sheet
Sirona Biochem financial ratios help investors to determine whether Sirona Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sirona with respect to the benefits of owning Sirona Biochem security.